Nereus Pharmaceuticals, Inc. We are a pioneer in the discovery and development of new therapeutics for cancer, inflammatory and infectious diseases that were derived from marine microbial sources. We have a clinical pipeline of two potentially best-in-class small molecule drugs for oncology that are in Phase 1 and 2 clinical trials. The pre-clinical pipeline consists of several new chemical entities that are modulators of NF-kB/IKK activity for the treatment of cancer and/or inflammatory diseases and two leads with novel pharmacophores that are broad spectrum antibiotics for infectious disease therapy.